Shaily Engineering
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Shaily Engineering's recent strategic pivot towards high-margin healthcare manufacturing, particularly in GLP-1 pen injectors, is a key driver of its expected revenue growth and margin expansion. Management's focus on operational excellence and capacity expansion, including the Abu Dhabi facility, aligns with Vista's forecast of a 29.3% CAGR in revenue and significant margin improvements. However, the company faces challenges from competitive pressures in the consumer segment and potential supply chain disruptions. The industrial components sector's stable growth and the increasing demand for precision engineering further support Shaily's outlook. Over the next 12-24 months, opportunities lie in the successful execution of healthcare contracts and diversification into semiconductor markets, while headwinds include geopolitical risks and fluctuating raw material costs. Overall, Shaily's strategic initiatives position it for long-term growth, although vigilance is required regarding execution risks and market dynamics
Why We Like This Stock
- Strategic focus on high-margin healthcare manufacturing, particularly GLP-1 pen injectors, is expected to drive significant revenue growth
- Capacity expansion initiatives, including the Abu Dhabi facility, are aligned with long-term growth projections and operational excellence
- Diversification into semiconductor markets and consumer electronics presents additional growth avenues
Things To Watch Out For
- Competitive pressures in the consumer segment may impact pricing power and margins
- Potential supply chain disruptions and geopolitical risks could hinder operational efficiency and cost management
- Fluctuations in raw material costs pose a risk to maintaining stable profit margins
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 644 | 787 | 991 | 1,021 | 1,164 |
| Profit Before Tax (Cr.) | 70 | 119 | 223 | 231 | 272 |
| PBT Margin | 10.9% | 15.1% | 22.5% | 22.6% | 23.4% |
| Net Profit (Cr.) | 61 | 96 | 179 | 184 | 218 |
| Earnings Per Share | 13.3 | 21.0 | 38.9 | 40.1 | 47.4 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| UBS | ▲ Buy | 4,500 | 21-Sep-2026 |
| Motilal Oswal | ▲ Buy | 4,074 | 10-Aug-2026 |
| Moneycontrol | ► Equalweight | nan | 25-Jun-2026 |
| Ventura | ▲ Buy | 3,124 | 06-May-2026 |
Company Overview
Show Company Profile
Shaily Engineering Plastics Limited engages in the manufacture and sale of precision injection moulded plastic components/products in India. The company offers specialty devices, platform devices, inhalers, sprays and pumps, intricate insulin injector pens, auto-injectors, and specialty packaging and containers for solid and liquid formulations, as well as providing contract development and manufacturing services for the pharmaceutical industry. It also offers kitchen and cooking devices, and storage and cleaning products; and sheet steel furniture products, including cabinets, drawer units, tables, and storage units. In addition, the company provides plastic components for lighting, appliances, and automotive applications; and razors, pumps, sprays and packaging for the personal care market. It also exports its products to approximately 40 countries. Shaily Engineering Plastics Limited was incorporated in 1980 and is based in Vadodara, India.